A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Completed · Phase 1 · Has a placebo group

Conditions studied: Growth Hormone Disorder, Adult Growth Hormone Deficiency, Healthy

In brief

This trial was conducted in the United States of America (USA). The aim of this clinical trial was to investigate the pharmacokinetics of somatropin in healthy Japanese and Caucasian subjects, and to identify somatostatin-related adverse events.

Key facts

Study ID

NCT00931476

Run by

Novo Nordisk A/S

People needed

86

Starts

2000-04-06

Expected to finish

2000-06-08

Last updated by the study team

2017-02-27

Who can join

Age: 20 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Signed informed consent before any trial related activities
• Japanese and Caucasian males respectively
• Healthy subjects based upon medical history, physical examination, vital signs, ECG, serum biochemistry and haematology and urinalysis
• Body Mass Index (BMI) between 17 and 30 m2/kg, inclusive

Where it is running

• Novo Nordisk Investigational Site — Honolulu, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.